BARBARA DELAUGHDER: Open Payments
NPI 1760055891 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$684 in 33 payments from 12 companies in 2025. Trend: 2023 $349 · 2024 $1,986 · 2025 $684
Food & beverage: $684
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 5 | $137 |
| Neurocrine BioSciences, Inc. | 5 | $110 |
| Otsuka America Pharmaceutical, Inc. | 4 | $81 |
| ABBVIE INC. | 3 | $59 |
| Janssen Pharmaceuticals, Inc | 3 | $57 |
| Vanda Pharmaceuticals Inc. | 3 | $54 |
| Lundbeck LLC | 3 | $53 |
| Axsome Therapeutics, Inc. | 3 | $50 |
| Alkermes, Inc. | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
Products named: COBENFY, INGREZZA, REXULTI, VRAYLAR, INVEGA SUSTENNA, ABILIFY MAINTENA, FANAPT, Auvelity.
Industry payments across OH — which companies pay providers there.
